Please complete the quiz on or before 22 August 2022 (Monday). We shall submit the CME accreditation for you after your submission of the quiz.

1. Which patient of the below is most likely to have the highest fracture risk?*

2. Which of the below best described patients who should be considered for initial treatment with Anabolic Agents?*

3. Which of the below description is NOT correct about the effect of bone forming agents?*

4. Which of the below description is correct when patients stopped anti-osteoporosis therapies (e.g. denosumab, alendronate, teriparatide) without subsequent treatments?*

5. Which of the below osteoporosis management approaches is the most appropriate to prevent fractures in patients?*
– The end –